Funded Researchers


2019-2020 Funding Cycle - Current Research Grant Recipients

To download a PDF with the lay abstract for each research project, click here.

image of Stephanie O. Berg, D.O.

Stephanie O. Berg, D.O. – Cardinal Bernardin Cancer Center,
Loyola University Medical Center (Maywood, Illinois)

Germline Mutations Predispose to Familial Myeloproliferative Neoplasms

image of Mario A. Blanco, Ph.D.

Mario A. Blanco, Ph.D. – University of Pennsylvania (Philadelphia, Pennsylvania)
Dual Targeting of LSD1 and KAT6A to Induce Therapeutic Differentiation in AML

image of Hamza Celik, Ph.D.

Hamza Celik, Ph.D. – Washington University School of Medicine (St. Louis, Missouri)
Generation of a Faithful Patient-derived Xenograft Model of Myelofibrosis for Pre-clinical Studies

image of Steven M. Chan, M.D., Ph.D.

Steven M. Chan, M.D., Ph.D. – Princess Margaret Cancer Centre (Toronto, Canada)
Repurposing Metformin to Prevent Blood Cancers and Cardiovascular Diseases Associated with TET2 Mutation-Driven Clonal Hematopoiesis

image of Raffaella Di Micco, Ph.D.

Raffaella Di Micco, Ph.D. – Ospedale San Raffaele (Milan, Italy)
Targeting of Epigenetic Drivers of Immune Evasion in Acute Myeloid Leukemia Relapses After Allogeneic HSCT

Daichi Inoue, M.D., Ph.D. – Institute of Biomedical Research and Innovation (IBRI) (Kobe City, Japan)
Understanding the Role of ZRSR2 Mutations in Myeloid Malignancies

image of Irum Khan, M.D.

Irum Khan, M.D. – University of Illinois at Chicago (Chicago, Illinois)
Targeting FOXM1 to Improve Treatment Responses in AML

image of Yongsoo Kim, Ph.D.

Yongsoo Kim, Ph.D. – VU University (Amsterdam, Netherlands)
A Computational Framework to Model Cellular Interplays in the Tumor Microenvironment of B Cell Lymphoma

image of Rui Lu, Ph.D.

Rui Lu, Ph.D. – University of Alabama (Birmingham, Alabama)
A Novel Stemness Program with Epigenetic Dysregulation in Acute Myeloid Leukemia

image of Michael Milyavsky, Ph.D.

Michael Milyavsky, Ph.D. – Tel Aviv University (Tel Aviv, Israel)
Harnessing Stemness Reporter to Identify and Target Critical Dependency Genes in Human Leukemia Stem Cells

image of Christopher Ott, Ph.D.

Christopher Ott, Ph.D. – Massachusetts General Hospital
(Charlestown, Massachusetts)

Deciphering Mechanisms of PAX5 Addiction in Lymphoma

image of Capucine Van Rechem, Ph.D.

Capucine Van Rechem, Ph.D. – Stanford University (Stanford, California)
Identify New Functions for PRMT5 in B-Cell Lymphoma to Unravel Therapeutic Strategies